Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (2016) Theis FJ, Corbacioglu A, Gaidzik VI, Paschka P, Weber D, Bullinger L, Heuser M, et al. Journal article CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis (2016) Braun M, Qorraj M, Büttner M, Klein FA, Saul D, Aigner M, Huber W, et al. Journal article Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia (2016) Mueller-Tidow C, Tschanter P, Roellig C, Thiede C, Koschmieder A, Stelljes M, Koschmieder S, et al. Journal article The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia (2016) Qorraj M, Bruns H, Böttcher M, Weigand L, Saul D, Mackensen A, Jitschin R, Mougiakakos D Journal article Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial (2016) Middeke JM, Herbst R, Parmentier S, Bug G, Haenel M, Stuhlers G, Schaefer-Eckart K, et al. Journal article Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV (2016) Miranda MB, Lauseker M, Kraus MP, Proetel U, Hanfstein B, Fabarius A, Baerlocher GM, et al. Journal article High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) (2016) Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Moehle R, Loew S, et al. Journal article Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial (2015) Schetelig J, Schaich M, Schaefer-Eckart K, Haenel M, Aulitzky WE, Einsele H, Schmitz N, et al. Journal article Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV (2015) Kalmanti L, Saussele S, Lauseker M, Mueller MC, Dietz CT, Heinrich L, Hanfstein B, et al. Journal article Insulin-like growth factor 1 is a direct HOXA9 target important for hematopoietic transformation (2015) Steger J, Füller E, Garcia-Cuellar MP, Hetzner K, Slany R Journal article, Original article